Biosimilars Market Trends: Accelerating Access to Cost-Effective Biologic Therapies Worldwide
The biosimilars industry is witnessing robust expansion as healthcare systems increasingly embrace affordable alternatives to expensive biologic medicines. Factors such as the growing burden of chronic diseases, the expiration of patents for blockbuster biologics, and supportive regulatory policies are driving market growth across multiple therapeutic areas. Biosimilars are developed to match...
0 Commenti 0 condivisioni 95 Views 0 Anteprima